- Home
- FOSL vs INMB Comparison
FOSL vs INMB Comparison
Compare FOSL & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- INMB
- Stock Information
- Founded
- FOSL 1984
- INMB 2015
- Country
- FOSL United States
- INMB United States
- Employees
- FOSL N/A
- INMB N/A
- Industry
- FOSL Consumer Specialties
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- INMB Health Care
- Exchange
- FOSL Nasdaq
- INMB Nasdaq
- Market Cap
- FOSL 112.2M
- INMB 112.0M
- IPO Year
- FOSL 1993
- INMB 2019
- Fundamental
- Price
- FOSL $1.85
- INMB $4.40
- Analyst Decision
- FOSL
- INMB Strong Buy
- Analyst Count
- FOSL 0
- INMB 2
- Target Price
- FOSL N/A
- INMB $21.00
- AVG Volume (30 Days)
- FOSL 2.3M
- INMB 215.6K
- Earning Date
- FOSL 11-07-2024
- INMB 10-31-2024
- Dividend Yield
- FOSL N/A
- INMB N/A
- EPS Growth
- FOSL N/A
- INMB N/A
- EPS
- FOSL N/A
- INMB N/A
- Revenue
- FOSL $1,223,954,000.00
- INMB $42,000.00
- Revenue This Year
- FOSL N/A
- INMB N/A
- Revenue Next Year
- FOSL N/A
- INMB N/A
- P/E Ratio
- FOSL N/A
- INMB N/A
- Revenue Growth
- FOSL N/A
- INMB N/A
- 52 Week Low
- FOSL $0.75
- INMB $4.32
- 52 Week High
- FOSL $2.61
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- FOSL 55.78
- INMB 37.57
- Support Level
- FOSL $1.64
- INMB $4.74
- Resistance Level
- FOSL $2.01
- INMB $5.16
- Average True Range (ATR)
- FOSL 0.19
- INMB 0.38
- MACD
- FOSL -0.03
- INMB -0.05
- Stochastic Oscillator
- FOSL 31.82
- INMB 5.56
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.